PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Academic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

Queen's University

Data updated April 9, 2026

Canada
5 Trials

The Centre for Psychedelics Health and Research, a joint project with Providence Care, aims to address fundamental questions regarding psychedelics in healthcare and expand clinical understanding of psychedelic-assisted therapies.

Academic Research

0 papers

Published Papers

0

Trial Involvement

5

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
Canada
Website
Visit

Sponsored Trials

3
Not yet recruitingI, II

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Start Date
October 1, 2025
Compounds
Ketamine
RecruitingII

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Start Date
May 6, 2025
Compounds
Psilocybin, Placebo
Unknown statusII

Combined Ketamine and eCBT Intervention for PTSD

Start Date
August 1, 2021
Compounds
Ketamine

Collaborated Trials

2
RecruitingI, II

Psilocybin for Psychological and Existential Distress in Palliative Care

Start Date
August 1, 2021
Compounds
Psilocybin
Temporarily not availableIII

Ketamine Versus Electroconvulsive Therapy in Depression

Start Date
October 29, 2018
Compounds
Ketamine, Placebo

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.